- In a briefing document regarding the meeting, the FDA said that it is hoping the committee will think about several items, including making the immunization schedule easier by giving specific kids, immunocompromised people, and older people two shots, but only one to other people.
- It also wants the panel to think about making a system for vaccination recommendations akin to the way the flu shot is handled every year.
- The document pointed out that the mRNA bivalent booster shots’ rollout “has been associated with significant implementation complexities,” adding that because of this and other available information, “a move to a single vaccine composition for primary and booster vaccinations should be considered.”
